Michael Zaiken

7PUBLICATIONS
47CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumoursAutoimmunityHaematology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jul 03, 2026
Human CD8-iTreg are potent GVHD suppressors and tumoricidal effectors by release of Granzyme-K + Supramolecular Attack Particles.

|Jul 23, 2025
Inflammasome-resistant IPSC-derived myeloid-derived suppressor cells ameliorate xenogeneic graft-versus-host disease.

Lie Ma, Brent Koehn, Michael Zaiken

|Feb 07, 2025
Targeting cell-surface VISTA expression on allospecific naïve T cells promotes tolerance.

Brent H Koehn, Elizabeth C Nowak, Sladjana Skopelja-Gardner

|Feb 03, 2025
Deficiency of T follicular helper cell Tet3 DNA demethylation inhibits pathogenic IgG2c class switching and chronic GVHD.

Michael C Zaiken, Sujeong Jin, Cameron S McDonald-Hyman

|Feb 28, 2022
BET-bromodomain and EZH2 inhibitor-treated chronic GVHD mice have blunted germinal centers with distinct transcriptomes.

Michael C Zaiken, Ryan Flynn, Katelyn G Paz

|Jan 11, 2022
Analyses and Correlation of Pathologic and Ocular Cutaneous Changes in Murine Graft versus Host Disease.

Robert B Levy, Hazem M Mousa, Casey O Lightbourn

Pageof 2

Frequent Collaborators

7 joint publications

Bruce R Blazar

4 joint publications

Keli L Hippen

3 joint publications

Sujeong Jin

3 joint publications

Jakub Tolar